Precigen
PGEN
#5462
Rank
NZ$2.25 B
Marketcap
NZ$6.36
Share price
-0.27%
Change (1 day)
364.44%
Change (1 year)

P/E ratio for Precigen (PGEN)

P/E ratio as of December 2025 (TTM): -6.25

According to Precigen's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -6.25424. At the end of 2021 the company had a P/E ratio of -7.89.

P/E ratio history for Precigen from 2013 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2021-7.89-21.06%
2020-10.00281.39%
2019-2.6256.36%
2018-1.68-85.73%
2017-11.8-22.88%
2016-15.2-62.76%
2015-40.929.13%
2014-31.71289.03%
2013-2.28

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Novocure
NVCR
-7.49 19.77% Jersey
Novavax
NVAX
3.20-151.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
-0.1771-97.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-2.69-56.93%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.